Product Information

OXYBUTYNIN CL ER 15 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1327 per EA under NDC 62135050990. Its NADAC has been published 176 times since Jul 12, 2023.

FDA first approved this application on Feb 4, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYBUTYNIN CL ER 15 MG TABLET

OXYBUTYNIN CHLORIDE
$0.1327per EA

Strength

15 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135050990

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXYBUTYNIN CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078503

FDA Approved

2/4/2009

TE Code

AB

On Market Since

3/1/2009

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for OXYBUTYNIN CL ER 15 MG TABLET has been published 176 times since Jul 12, 2023, and over the history we have for it it has declined 16.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1327 per EA
All-time high$0.1735 (Sep 13, 2023)
All-time low$0.0936 (Apr 17, 2024)
52-week high$0.1327
52-week low$0.1161
Median price$0.1300
Average price$0.1317
Largest weekly change+38.9% (May 22, 2024)
Weeks tracked176
Tracking sinceJul 12, 2023

Price History

1W

+3.1%

1M

+6.1%

3M

+5.9%

6M

+14.2%

1Y

+11.1%

3Y

-0.8%

5Y

N/A

All

-16.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXYBUTYNIN CHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXYBUTYNIN CL ER 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 15 MG TABLET, manufactured by Chartwell RX LLC, is $0.1327 per EA (NDC 62135050990), effective Nov 18, 2026.

How has the price of OXYBUTYNIN CL ER 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has declined 16.5%. It has been tracked across 176 weekly CMS publications since Jul 12, 2023.

What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 15 MG TABLET?

Since Jul 12, 2023, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has ranged from a low of $0.0936 (Apr 17, 2024) to a high of $0.1735 (Sep 13, 2023), with a median of $0.1300 per EA.

Are there cheaper alternatives to OXYBUTYNIN CL ER 15 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of OXYBUTYNIN CL ER 15 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OXYBUTYNIN CL ER 15 MG TABLET?

OXYBUTYNIN CL ER 15 MG TABLET (NDC 62135050990) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.